John C. Tilton

3.7k citations
35 papers · 2.4k indexed · 2 hit papers · h-index 22

Impact in

  • Virology top 0.5%
    • HIV Research and Treatment
    • HIV/AIDS drug development and treatment
    • COVID-19 Clinical Research Studies
    • HIV/AIDS Research and Interventions

Papers in

    • HIV Research and Treatment 28
    • HIV/AIDS drug development and treatment 17
    • HIV/AIDS Research and Interventions 7
    • SARS-CoV-2 and COVID-19 Research 3

John C. Tilton

35 papers receiving 2.4k citations

Hit Papers

COVID-19 and Cardiovascular Disease 2021 · 251 citations
2512012202620162021100200300400

Peers

John C. Tilton
Comparison fields: 5 of 119
  • Virology 1.2k
  • Infectious Diseases 969
  • Immunology 907
  • Hepatology 153
  • Epidemiology 468
Replace Manish Sagar with:
Manish Sagar United States
Thomas Harrer Germany
Jean‐Marie Andrieu France
Jinghe Huang China
Emi E. Nakayama Japan
Elisa Vicenzi Italy
Gianpiero D’Offizi Italy
Yuntao Wu United States
Ramin B. Arani United States
Chiara Agrati Italy
John C. Tilton relative to Manish Sagar United States Manish Sagar's profile →
Citations per field
00.5×1.5×2.1×
Manish Sagar · 1×
Citations per year

Countries citing papers authored by John C. Tilton

Since Specialization
Citations

This map shows the geographic impact of John C. Tilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Tilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Tilton more than expected).

Fields of papers citing papers by John C. Tilton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Tilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Tilton. The network helps show where John C. Tilton may publish in the future.

Co-authors

The 25 scholars most cited alongside John C. Tilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John C. Tilton Line = papers co-authored together John C. Tilton links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2
COVID-19 and Cardiovascular Disease
Hit paper breakdown →
2021251
3 202155
4 20213
5 202096
6 20208
7 20189
8 201743
9 201720
10 20179
11 20154
12 201441
13 2013102
14 201313
15 2011163
16 201044
17 2009163
18 200870
19 20066
20 200664

About John C. Tilton

John C. Tilton is a scholar working on Virology, Infectious Diseases, Immunology, Hepatology and Epidemiology, having authored 35 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (17 papers), Immune Cell Function and Interaction (16 papers), HIV/AIDS Research and Interventions (7 papers), T-cell and B-cell Immunology (6 papers), Mosquito-borne diseases and control (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Virology (1.2k citations), Infectious Diseases (969 citations), Immunology (907 citations), Hepatology (153 citations) and Epidemiology (468 citations). John C. Tilton has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert W. Doms, Craig B. Wilen, Mark Connors, Eric O. Long, Carsten Watzl, Philipp Eissmann, Julia A. Metcalf, Claire W. Hallahan, Alison J. Johnson and Scott J. Cameron. Their work appears in journals such as Journal of Virology, Viruses, Retrovirology, Antiviral Research and Current HIV/AIDS Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026